课题基金 / 基金详情

Development of novel gene therapy for hormone refractory prostate cancer

Development of novel gene therapy for hormone refractory prostate cancer
开发激素难治性前列腺癌的新型基因疗法
批准号:
20591868
负责人:
KIYOTA Hiroshi
金额:
$3.0万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

KIYOTA Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of this study is to develop the new gene therapy using lentiviral vector with prostate-specific promoter that induces therapeutic gene to prostate cancer specifically. Lentiviral vectors with prostate-specific promoters were constructed and the efficiency was observed in vitro and in vivo models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analysis of integrins in lymphnode metastasis of bladder cancer
  • 批准号:
    12671560
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.11万
  • 财政年份:
    2000
  • 负责人:
    KIYOTA Hiroshi
  • 依托单位:
海外基金